4The Emerging Risk Factors Collaboration.Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies[J]. The Lancet . 2010 (9733)
5HE J, GU D,CHEN J,et al. Premature deaths attribut-able to blood pressure in China :a prospective cohortstudy [ J ]. The Lancet, 2009,374 ( 9703 ) :1765 -1772.
6SMART N A, STEELE M. Systematic review of the effectof aerobic and resistance exercise training on systemicbrain natriuretic peptide ( BNP) and N-terminal BNP ex-pression in heart failure patients [ J ]. International Jour-nal of Cardiology, 2010,140(3) :260 -265.
7VALLI N,G0BINET A, BORDENAVE L,et al. Reviewof 10 years of the clinical use of brain natriuretic peptidein cardiology[ J]. Lab Clin Med, 1999,134(5) :437 -444.
8HASEGAWA H, TAKANO H, KOHRO T, et al. Amel-ioration of hypertensive heart failure by amlodipine mayoccur via antioxidative effects [ J ]. Hypertension Re-search, 2006,29(9) :719 -729.
9SWEDBERG K,CLELAND J, DARGIE H, et al.Guidelines for the diagnosis and treatment of chronic heartfailure :executive summary ( update 2005 ). The taskforce for the diagnosis and treatment of chronic heart fail-ure of the European Society of Cardiology [ J]. EuropeanHeart Journal, 2005 , 26 ( 11 ) ; 1115 - 1140.
10Jwu-Lai Yeh,Jong-Hau Hsu,Jyh-Chong Liang,Ing-Jun Chen,Shu-Fen Liou.Lercanidipine and labedipinedilol-A attenuate lipopolysaccharide/interferon-γ-induced inflammation in rat vascular smooth muscle cells through inhibition of HMGB1 release and MMP-2, 9 activities[J].Atherosclerosis.2012
